Charles River Laboratories International (CRL) Long-Term Investments (2020 - 2025)
Historic Long-Term Investments for Charles River Laboratories International (CRL) over the last 8 years, with Q3 2025 value amounting to $194.6 million.
- Charles River Laboratories International's Long-Term Investments rose 5454.09% to $194.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.6 million, marking a year-over-year increase of 5454.09%. This contributed to the annual value of $218.4 million for FY2024, which is 1044.29% down from last year.
- Per Charles River Laboratories International's latest filing, its Long-Term Investments stood at $194.6 million for Q3 2025, which was up 5454.09% from $216.1 million recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Long-Term Investments ranged from a high of $311.6 million in Q4 2022 and a low of $60.6 million during Q1 2022
- Its 5-year average for Long-Term Investments is $200.8 million, with a median of $207.7 million in 2021.
- Its Long-Term Investments has fluctuated over the past 5 years, first surged by 71505.83% in 2021, then crashed by 6044.31% in 2024.
- Over the past 5 years, Charles River Laboratories International's Long-Term Investments (Quarter) stood at $201.4 million in 2021, then skyrocketed by 54.75% to $311.6 million in 2022, then dropped by 21.76% to $243.8 million in 2023, then decreased by 10.44% to $218.4 million in 2024, then fell by 10.86% to $194.6 million in 2025.
- Its Long-Term Investments was $194.6 million in Q3 2025, compared to $216.1 million in Q2 2025 and $214.0 million in Q1 2025.